Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (TA304)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 February 2014
Secukinumab for treating relapsed polymyalgia rheumatica [ID6599]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC